FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148493990> ?p ?o ?g. }

• W2148493990 endingPage "R2" @default.
• W2148493990 startingPage "R2" @default.
• W2148493990 abstract "An international cohort study of 73 anti-Ku-positive patients with different connective tissue diseases was conducted to differentiate the anti-Ku-positive populations of patients based on their autoantibody profile and clinical signs/symptoms and to establish possible correlations between antibodies against Ku p70 and Ku p80 with autoimmune diseases. Sera of anti-Ku-positive patients were collected from six European centers and were all secondarily tested (in the reference center); 73 were confirmed as positive. Anti-Ku antibodies were detected with counter-immunoelectrophoresis (CIE), line immunoassay (LIA), and immunoblot analyses. All clinical and laboratory data were follow-up cumulative data, except for anti-Ku antibodies. Statistical analyses were performed by using R (V 2.12.1). The Fisher Exact test was used to evaluate the association between anti-Ku antibodies and diagnosis, gender, clinical signs, and other observed antibodies. The P values were adjusted for multiple testing. Separation of disease populations based on the presence of antibodies and clinical signs was investigated by principal-components analysis, which was performed by using thr// R's prcomp function with standard parameters. A 16% higher prevalence of anti-Ku p70 was found over anti-Ku p80 antibodies. In 41 (57%) patients, a combination of both was detected. Five (7%) patients, who were CIE and/or LIA anti-Ku positive, were negative for both subsets, as detected with the immunoblot; 31% of the patients had undifferentiated connective tissue disease (UCTD); 29% had systemic sclerosis (SSc); 18% had systemic lupus erythematosus (SLE); 11% had rheumatoid arthritis; 7% had polymyositis; and 3% had Sjögren syndrome. A significant positive association was found between female patients with anti-Ku p70 and joint/bone features, and a significant negative association was found between female patients with anti-Ku p80 only and joint/bone features (P = 0.05, respectively). By using the first and the third components of the principal-component analysis (PCA) with 29 parameters evaluated, we observed that the anti-Ku-positive population of UCTD patients had overlapping parameters, especially with SLE, as opposed to SSc, which could be helpful in delineating UCTD patients." @default.
• W2148493990 created "2016-06-24" @default.
• W2148493990 creator A5006490409 @default.
• W2148493990 creator A5009077314 @default.
• W2148493990 creator A5021292232 @default.
• W2148493990 creator A5033906950 @default.
• W2148493990 creator A5035674380 @default.
• W2148493990 creator A5036400874 @default.
• W2148493990 creator A5036934250 @default.
• W2148493990 creator A5037371186 @default.
• W2148493990 creator A5039032334 @default.
• W2148493990 creator A5043580027 @default.
• W2148493990 creator A5054047592 @default.
• W2148493990 creator A5059359523 @default.
• W2148493990 creator A5060748260 @default.
• W2148493990 creator A5071541433 @default.
• W2148493990 creator A5073883126 @default.
• W2148493990 creator A5079921904 @default.
• W2148493990 creator A5081344290 @default.
• W2148493990 creator A5083778574 @default.
• W2148493990 creator A5084185428 @default.
• W2148493990 creator A5086709802 @default.
• W2148493990 creator A5091190600 @default.
• W2148493990 date "2012-01-01" @default.
• W2148493990 modified "2023-10-18" @default.
• W2148493990 title "International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis" @default.
• W2148493990 cites W1963665717 @default.
• W2148493990 cites W196512513 @default.
• W2148493990 cites W1976589969 @default.
• W2148493990 cites W1981950544 @default.
• W2148493990 cites W2018609920 @default.
• W2148493990 cites W2030776068 @default.
• W2148493990 cites W2045751930 @default.
• W2148493990 cites W2054330426 @default.
• W2148493990 cites W2152348310 @default.
• W2148493990 cites W2159314125 @default.
• W2148493990 cites W2167385753 @default.
• W2148493990 cites W4211050134 @default.
• W2148493990 doi "https://doi.org/10.1186/ar3550" @default.
• W2148493990 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3392788" @default.
• W2148493990 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22226402" @default.
• W2148493990 hasPublicationYear "2012" @default.
• W2148493990 type Work @default.
• W2148493990 sameAs 2148493990 @default.
• W2148493990 citedByCount "20" @default.
• W2148493990 countsByYear W21484939902013 @default.
• W2148493990 countsByYear W21484939902015 @default.
• W2148493990 countsByYear W21484939902016 @default.
• W2148493990 countsByYear W21484939902017 @default.
• W2148493990 countsByYear W21484939902019 @default.
• W2148493990 countsByYear W21484939902020 @default.
• W2148493990 countsByYear W21484939902021 @default.
• W2148493990 countsByYear W21484939902023 @default.
• W2148493990 crossrefType "journal-article" @default.
• W2148493990 hasAuthorship W2148493990A5006490409 @default.
• W2148493990 hasAuthorship W2148493990A5009077314 @default.
• W2148493990 hasAuthorship W2148493990A5021292232 @default.
• W2148493990 hasAuthorship W2148493990A5033906950 @default.
• W2148493990 hasAuthorship W2148493990A5035674380 @default.
• W2148493990 hasAuthorship W2148493990A5036400874 @default.
• W2148493990 hasAuthorship W2148493990A5036934250 @default.
• W2148493990 hasAuthorship W2148493990A5037371186 @default.
• W2148493990 hasAuthorship W2148493990A5039032334 @default.
• W2148493990 hasAuthorship W2148493990A5043580027 @default.
• W2148493990 hasAuthorship W2148493990A5054047592 @default.
• W2148493990 hasAuthorship W2148493990A5059359523 @default.
• W2148493990 hasAuthorship W2148493990A5060748260 @default.
• W2148493990 hasAuthorship W2148493990A5071541433 @default.
• W2148493990 hasAuthorship W2148493990A5073883126 @default.
• W2148493990 hasAuthorship W2148493990A5079921904 @default.
• W2148493990 hasAuthorship W2148493990A5081344290 @default.
• W2148493990 hasAuthorship W2148493990A5083778574 @default.
• W2148493990 hasAuthorship W2148493990A5084185428 @default.
• W2148493990 hasAuthorship W2148493990A5086709802 @default.
• W2148493990 hasAuthorship W2148493990A5091190600 @default.
• W2148493990 hasBestOaLocation W21484939901 @default.
• W2148493990 hasConcept C126322002 @default.
• W2148493990 hasConcept C149443304 @default.
• W2148493990 hasConcept C159654299 @default.
• W2148493990 hasConcept C163764329 @default.
• W2148493990 hasConcept C198451711 @default.
• W2148493990 hasConcept C203014093 @default.
• W2148493990 hasConcept C2776232647 @default.
• W2148493990 hasConcept C2776670291 @default.
• W2148493990 hasConcept C2777575956 @default.
• W2148493990 hasConcept C2778962941 @default.
• W2148493990 hasConcept C2779075594 @default.
• W2148493990 hasConcept C71924100 @default.
• W2148493990 hasConcept C90924648 @default.
• W2148493990 hasConceptScore W2148493990C126322002 @default.
• W2148493990 hasConceptScore W2148493990C149443304 @default.
• W2148493990 hasConceptScore W2148493990C159654299 @default.
• W2148493990 hasConceptScore W2148493990C163764329 @default.
• W2148493990 hasConceptScore W2148493990C198451711 @default.
• W2148493990 hasConceptScore W2148493990C203014093 @default.
• W2148493990 hasConceptScore W2148493990C2776232647 @default.
• W2148493990 hasConceptScore W2148493990C2776670291 @default.
• W2148493990 hasConceptScore W2148493990C2777575956 @default.

• next